Psychotherapy and Management of Personality Disorders

Structured psychotherapy is the cornerstone of treatment for personality disorders, especially borderline personality disorder, where several manualised approaches have been developed and tested in randomized trials. This entry orients the reader to the major evidence-based psychotherapies and the principles of management, summarising the evidence base rather than prescribing care.

Definition

Psychotherapy for personality disorders refers to structured, theory-based psychological treatments, typically delivered over months, that aim to reduce symptoms such as self-harm and emotional dysregulation and to improve interpersonal and overall functioning; in personality disorders these treatments are generally regarded as the primary modality.

Scope

The entry covers the leading psychotherapeutic models for personality disorders (notably dialectical behavior therapy, mentalization-based treatment, transference-focused psychotherapy, and schema therapy), the role of generalist structured care, and the limited and adjunctive place of pharmacotherapy. It is reference-educational and contains no dosing or individualised treatment instructions.

Core questions

• Which structured psychotherapies have the strongest evidence for personality disorders?
• How do specialist psychotherapies compare with well-structured generalist care?
• What is the appropriate, limited role of medication?

Key concepts

• Dialectical behavior therapy
• Mentalization-based treatment
• Transference-focused psychotherapy
• Schema therapy
• Structured clinical management / generalist care
• Adjunctive and symptom-targeted pharmacotherapy
• Treatment retention and therapeutic alliance

Mechanisms

The leading therapies share structure, an explicit treatment frame, attention to self-harm and crisis management, and a focus on emotion regulation and interpersonal functioning, while differing in emphasis: dialectical behavior therapy combines behavioural skills training with validation; mentalization-based treatment targets the capacity to understand mental states in self and others; transference-focused and schema therapies work with internal representations and maladaptive schemas. Trials and meta-analyses indicate that this common structure, rather than any single brand, accounts for much of the benefit.

Clinical relevance

Because personality disorders are chronic and impairing, access to evidence-based psychotherapy can reduce self-harm and improve functioning; recognising which treatments are supported by evidence informs critical reading of the literature and service planning. This entry summarises the evidence and is explicitly non-prescriptive; it gives no dosing, regimen, or individualised treatment advice.

Evidence & guidelines

Randomized trials by Linehan and colleagues (dialectical behavior therapy) and by Bateman and Fonagy (mentalization-based treatment) established efficacy for borderline personality disorder. The meta-analysis by Cristea and colleagues found that psychotherapies, especially dialectical behavior therapy and psychodynamic approaches, were more effective than control conditions, while the Cochrane review by Storebø and colleagues reached broadly favourable but cautious conclusions given evidence limitations. Guidelines generally position structured psychotherapy as first-line and medication as adjunctive and targeted rather than curative.

History

Until the late twentieth century personality disorders were widely regarded as untreatable. Linehan's development of dialectical behavior therapy and its 1991 trial, followed by Bateman and Fonagy's mentalization-based treatment and by transference-focused and schema therapies, demonstrated that structured psychotherapy could reduce self-harm and improve outcomes, transforming the field's outlook and prompting guideline recommendations for psychotherapy as first-line care.

Debates

Are specialist brand-name therapies superior to good generalist care?

Several trials comparing specialist treatments with well-structured generalist or clinical management show smaller differences than expected, raising the question of how much benefit derives from specific techniques versus shared structure, expertise, and a coherent treatment frame.

Key figures

• Marsha Linehan
• Anthony Bateman
• Peter Fonagy
• Otto Kernberg
• Jeffrey Young

Seminal works

• linehan-1991
• bateman-fonagy-2009
• cristea-2017
• storebo-2020

Frequently asked questions

What is the first-line treatment for personality disorders?

For borderline personality disorder in particular, structured disorder-specific psychotherapy is generally regarded as first-line, with several manualised approaches supported by randomized trials; this entry describes the evidence and is not treatment advice.

Is medication used to treat personality disorders?

Medication is generally considered adjunctive and aimed at specific symptoms or comorbid conditions rather than at the personality disorder itself; no drug is established as a primary or curative treatment, and decisions belong to a qualified clinician.